P48634 (PRC2A_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
April 3, 2013.
Version 114.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Protein PRRC2A Alternative name(s): HLA-B-associated transcript 2 Large proline-rich protein BAT2 Proline-rich and coiled-coil-containing protein 2A Protein G2 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 2157 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | May play a role in the regulation of pre-mRNA splicing. Ref.10 |
| Subcellular location | |
| Tissue specificity | Limited to cell-lines of leukemic origin. |
| Developmental stage | Broadly expressed during the 11th week of gestation, with highest levels in the central nervous system, spinal ganglia, osteoblasts and osteocytes (at protein level). Ref.11 |
| Sequence caution | The sequence AAA35585.1 differs from that shown. Reason: Frameshift at positions 38 and 58. The sequence AAA35586.1 differs from that shown. Reason: Frameshift at positions 38 and 58. The sequence BAE06116.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally shortened. The sequence CAA78744.1 differs from that shown. Reason: Frameshift at positions 38 and 58. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cytoplasm Nucleus |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | Repeat |
| PTM | Acetylation Phosphoprotein |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Cellular_component | cytoplasm Inferred from electronic annotation. Source: UniProtKB-SubCell nucleusInferred from electronic annotation. Source: UniProtKB-SubCell |
| Complete GO annotation... | |
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| ATXN1 | P54253 | 4 | EBI-347545,EBI-930964 | |
| JUN | P05412 | 2 | EBI-347545,EBI-852823 |
Alternative products
| This entry describes 4 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P48634-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P48634-2) The sequence of this isoform differs from the canonical sequence as follows: 413-424: Missing. 1050-1148: RSREFRSYRE...PPPPGAPPSP → QANSAVTESF...PTTRSPTLHR 1155-1177: ARGGRVFTPRGVPSRRGRGGGRP → CPGVGESSLPEGAISPGPRRREA 1852-1864: AMDSQLHPNSGGF → SHGLSITSKQWRL | ||||||
| Isoform 3 (identifier: P48634-3) The sequence of this isoform differs from the canonical sequence as follows: 1050-1148: RSREFRSYRE...PPPPGAPPSP → QANSAVTESF...PTTRSPTLHR 1155-1177: ARGGRVFTPRGVPSRRGRGGGRP → CPGVGESSLPEGAISPGPRRREA 1852-1864: AMDSQLHPNSGGF → SHGLSITSKQWRL | ||||||
| Isoform 4 (identifier: P48634-4) The sequence of this isoform differs from the canonical sequence as follows: 834-1457: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 2157 | 2157 | Protein PRRC2A | PRO_0000064829 | |||||
Regions | |||||||||
| Repeat | 41 – 95 | 55 | 1-1 | ||||||
| Repeat | 98 – 154 | 57 | 1-2 | ||||||
| Repeat | 281 – 337 | 57 | 1-3 | ||||||
| Repeat | 337 – 430 | 94 | 2-1 | ||||||
| Repeat | 488 – 561 | 74 | 2-2 | ||||||
| Repeat | 1757 – 1812 | 56 | 1-4 | ||||||
| Repeat | 1916 – 1965 | 50 | 3-1 | ||||||
| Repeat | 1982 – 2031 | 50 | 3-2 | ||||||
| Repeat | 2057 – 2106 | 50 | 3-3 | ||||||
| Region | 41 – 1812 | 1772 | 4 X 57 AA type A repeats | ||||||
| Region | 337 – 561 | 225 | 2 X type B repeats | ||||||
| Region | 1916 – 2106 | 191 | 3 X 50 AA type C repeats | ||||||
| Compositional bias | 466 – 471 | 6 | Poly-Arg | ||||||
| Compositional bias | 472 – 475 | 4 | Poly-Glu | ||||||
| Compositional bias | 658 – 669 | 12 | Poly-Gln | ||||||
| Compositional bias | 696 – 700 | 5 | Poly-Pro | ||||||
| Compositional bias | 826 – 833 | 8 | Poly-Pro | ||||||
| Compositional bias | 913 – 916 | 4 | Poly-Pro | ||||||
| Compositional bias | 955 – 958 | 4 | Poly-Pro | ||||||
| Compositional bias | 1139 – 1142 | 4 | Poly-Pro | ||||||
| Compositional bias | 1239 – 1244 | 6 | Poly-Arg | ||||||
| Compositional bias | 1355 – 1360 | 6 | Poly-Gly | ||||||
| Compositional bias | 1413 – 1421 | 9 | Poly-Gly | ||||||
| Compositional bias | 1451 – 1457 | 7 | Poly-Pro | ||||||
Amino acid modifications | |||||||||
| Modified residue | 27 | 1 | N6-acetyllysine Ref.17 | ||||||
| Modified residue | 166 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 342 | 1 | Phosphoserine Ref.12 Ref.20 | ||||||
| Modified residue | 350 | 1 | Phosphoserine Ref.12 Ref.20 | ||||||
| Modified residue | 380 | 1 | Phosphoserine Ref.15 Ref.16 Ref.18 Ref.20 | ||||||
| Modified residue | 383 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 456 | 1 | Phosphoserine Ref.15 Ref.16 | ||||||
| Modified residue | 610 | 1 | Phosphothreonine Ref.15 Ref.16 | ||||||
| Modified residue | 759 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 761 | 1 | Phosphoserine Ref.15 Ref.16 | ||||||
| Modified residue | 764 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 782 | 1 | Phosphothreonine By similarity | ||||||
| Modified residue | 808 | 1 | Phosphoserine Ref.18 | ||||||
| Modified residue | 1004 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 1014 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 1085 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 1089 | 1 | Phosphoserine Ref.12 Ref.15 Ref.16 Ref.20 | ||||||
| Modified residue | 1092 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 1094 | 1 | Phosphotyrosine Ref.15 | ||||||
| Modified residue | 1110 | 1 | Phosphoserine Ref.20 | ||||||
| Modified residue | 1147 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 1196 | 1 | N6-acetyllysine Ref.17 | ||||||
| Modified residue | 1219 | 1 | Phosphoserine Ref.14 Ref.18 Ref.20 | ||||||
| Modified residue | 1306 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 1353 | 1 | Phosphothreonine Ref.18 | ||||||
| Modified residue | 2113 | 1 | Phosphoserine Ref.18 | ||||||
Natural variations | |||||||||
| Alternative sequence | 413 – 424 | 12 | Missing in isoform 2. | VSP_015099 | |||||
| Alternative sequence | 834 – 1457 | 624 | Missing in isoform 4. | VSP_030865 | |||||
| Alternative sequence | 1050 – 1148 | 99 | RSREF…APPSP → QANSAVTESFEEMMGVEVGQ GDQTTLLLPEAAMPARHGAR VQSMRKSPSGAGSGAQKQAA RPMRVIWLLQTRRLPHPRRE HSPRSSRSPTTRSPTLHR in isoform 2 and isoform 3. | VSP_015100 | |||||
| Alternative sequence | 1155 – 1177 | 23 | ARGGR…GGGRP → CPGVGESSLPEGAISPGPRR REA in isoform 2 and isoform 3. | VSP_015101 | |||||
| Alternative sequence | 1852 – 1864 | 13 | AMDSQ…NSGGF → SHGLSITSKQWRL in isoform 2 and isoform 3. | VSP_015102 | |||||
| Natural variant | 57 | 1 | P → R. Ref.1 Corresponds to variant rs1062968 [ dbSNP | Ensembl ]. | VAR_023215 | |||||
| Natural variant | 82 | 1 | D → V. Corresponds to variant rs6921213 [ dbSNP | Ensembl ]. | VAR_045992 | |||||
| Natural variant | 106 | 1 | P → L. Ref.2 Ref.5 Corresponds to variant rs2280801 [ dbSNP | Ensembl ]. | VAR_023216 | |||||
| Natural variant | 477 | 1 | R → C. Ref.7 Corresponds to variant rs17857493 [ dbSNP | Ensembl ]. | VAR_045993 | |||||
| Natural variant | 544 | 1 | T → K. Ref.2 Ref.3 Ref.4 Ref.5 Ref.6 Ref.7 Ref.8 Corresponds to variant rs1046080 [ dbSNP | Ensembl ]. | VAR_023217 | |||||
| Natural variant | 694 | 1 | Q → K. Ref.8 Corresponds to variant rs2844469 [ dbSNP | Ensembl ]. | VAR_023218 | |||||
| Natural variant | 742 | 1 | D → E. Ref.1 Corresponds to variant rs1046081 [ dbSNP | Ensembl ]. | VAR_023219 | |||||
| Natural variant | 804 | 1 | R → C. Corresponds to variant rs11538262 [ dbSNP | Ensembl ]. | VAR_045994 | |||||
| Natural variant | 1087 | 1 | T → I in a breast cancer sample; somatic mutation. Ref.21 | VAR_035796 | |||||
| Natural variant | 1152 | 1 | R → H in a breast cancer sample; somatic mutation. Ref.21 | VAR_035797 | |||||
| Natural variant | 1285 | 1 | G → A. Ref.3 Corresponds to variant rs2736158 [ dbSNP | Ensembl ]. | VAR_023220 | |||||
| Natural variant | 1407 | 1 | S → N. Corresponds to variant rs35464047 [ dbSNP | Ensembl ]. | VAR_045995 | |||||
| Natural variant | 1415 | 1 | G → A. Ref.8 Corresponds to variant rs2857703 [ dbSNP | Ensembl ]. | VAR_023221 | |||||
| Natural variant | 1503 | 1 | L → P. Ref.1 Ref.2 Ref.3 Ref.4 Ref.5 Ref.6 Ref.7 Ref.8 Ref.9 Corresponds to variant rs2272593 [ dbSNP | Ensembl ]. | VAR_023222 | |||||
| Natural variant | 1544 | 1 | G → D. Corresponds to variant rs34175432 [ dbSNP | Ensembl ]. | VAR_045996 | |||||
| Natural variant | 1563 | 1 | R → Q. Corresponds to variant rs11538263 [ dbSNP | Ensembl ]. | VAR_045997 | |||||
| Natural variant | 1740 | 1 | R → H. Ref.3 Ref.5 Ref.6 Corresponds to variant rs1046089 [ dbSNP | Ensembl ]. | VAR_023223 | |||||
| Natural variant | 1744 | 1 | G → A. Ref.8 Corresponds to variant rs2844491 [ dbSNP | Ensembl ]. | VAR_023224 | |||||
| Natural variant | 1774 | 1 | V → M. Corresponds to variant rs11538264 [ dbSNP | Ensembl ]. | VAR_045998 | |||||
| Natural variant | 1775 | 1 | V → M. Corresponds to variant rs11538264 [ dbSNP | Ensembl ]. | VAR_023225 | |||||
| Natural variant | 1895 | 1 | L → V. Ref.1 Ref.2 Ref.3 Ref.4 Ref.5 Ref.6 Ref.7 Ref.9 Corresponds to variant rs3132453 [ dbSNP | Ensembl ]. | VAR_023226 | |||||
| Natural variant | 2006 | 1 | P → S. Ref.5 Corresponds to variant rs10885 [ dbSNP | Ensembl ]. | VAR_023227 | |||||
| Natural variant | 2075 | 1 | R → W. Corresponds to variant rs34137317 [ dbSNP | Ensembl ]. | VAR_056742 | |||||
| Natural variant | 2130 | 1 | P → L. Ref.3 Corresponds to variant rs1046756 [ dbSNP | Ensembl ]. | VAR_023228 | |||||
Experimental info | |||||||||
| Sequence conflict | 57 | 1 | P → A in CAA78744. Ref.8 | ||||||
| Sequence conflict | 107 – 123 | 17 | ESQPL…SNQPK → NRTTAGFTDACLQPAE in CAA78744. Ref.8 | ||||||
| Sequence conflict | 762 | 1 | G → L in AAA35585. Ref.1 | ||||||
| Sequence conflict | 762 | 1 | G → L in AAA35586. Ref.1 | ||||||
| Sequence conflict | 762 | 1 | G → R in CAA78744. Ref.8 | ||||||
| Sequence conflict | 764 | 1 | S → L in AAA35585. Ref.1 | ||||||
| Sequence conflict | 764 | 1 | S → L in AAA35586. Ref.1 | ||||||
| Sequence conflict | 764 | 1 | S → L in CAA78744. Ref.8 | ||||||
| Sequence conflict | 846 | 1 | A → T in CAA78744. Ref.8 | ||||||
| Sequence conflict | 902 – 911 | 10 | PARGVGSGGQ → LPASRSGA in AAA35585. Ref.1 | ||||||
| Sequence conflict | 902 – 911 | 10 | PARGVGSGGQ → LPASRSGA in AAA35586. Ref.1 | ||||||
| Sequence conflict | 902 – 911 | 10 | PARGVGSGGQ → LPASRSGA in CAA78744. Ref.8 | ||||||
| Sequence conflict | 934 | 1 | R → G in AAH42295. Ref.7 | ||||||
| Sequence conflict | 1049 | 1 | A → G in AAA35585. Ref.1 | ||||||
| Sequence conflict | 1049 | 1 | A → G in AAA35586. Ref.1 | ||||||
| Sequence conflict | 1300 | 1 | R → P in AAA35585. Ref.1 | ||||||
| Sequence conflict | 1300 | 1 | R → P in AAA35586. Ref.1 | ||||||
| Sequence conflict | 1461 | 1 | Missing in CAA78744. Ref.8 | ||||||
| Sequence conflict | 1626 | 1 | S → T in AAA35585. Ref.1 | ||||||
| Sequence conflict | 1626 | 1 | S → T in AAA35586. Ref.1 | ||||||
| Isoform 3: | |||||||||
| Sequence conflict | 1082 | 1 | M → L in CAA78744. Ref.8 | ||||||
Sequences
| ||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "A gene pair from the human major histocompatibility complex encodes large proline-rich proteins with multiple repeated motifs and a single ubiquitin-like domain." Banerji J., Sands J., Strominger J.L., Spies T. Proc. Natl. Acad. Sci. U.S.A. 87:2374-2378(1990) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 2), VARIANTS ARG-57; GLU-742; PRO-1503 AND VAL-1895. Tissue: T-cell. |
| [2] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), VARIANTS LEU-106; LYS-544; PRO-1503 AND VAL-1895. Tissue: Brain. |
| [3] | "Analysis of the gene-dense major histocompatibility complex class III region and its comparison to mouse." Xie T., Rowen L., Aguado B., Ahearn M.E., Madan A., Qin S., Campbell R.D., Hood L. Genome Res. 13:2621-2636(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], VARIANTS LYS-544; ALA-1285; PRO-1503; HIS-1740; VAL-1895 AND LEU-2130. |
| [4] | "Homo sapiens 2,229,817bp genomic DNA of 6p21.3 HLA class I region." Shiina S., Tamiya G., Oka A., Inoko H. Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], VARIANTS LYS-544; PRO-1503 AND VAL-1895. |
| [5] | "The DNA sequence and analysis of human chromosome 6." Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D., Andrews T.D. Beck S.Nature 425:805-811(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], VARIANTS LEU-106; LYS-544; PRO-1503; HIS-1740; VAL-1895 AND SER-2006. |
| [6] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], VARIANTS LYS-544; PRO-1503; HIS-1740 AND VAL-1895. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), VARIANTS CYS-477; LYS-544; PRO-1503 AND VAL-1895. Tissue: Lymph, Placenta and Uterus. |
| [8] | "Dense Alu clustering and a potential new member of the NF kappa B family within a 90 kilobase HLA class III segment." Iris F.J.M., Bougueleret L., Prieur S., Caterina D., Primas G., Perrot V., Jurka J., Rodriguez-Tome P., Claverie J.-M., Dausset J., Cohen D. Nat. Genet. 3:137-145(1993) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-1874 (ISOFORM 3), VARIANTS LYS-544; LYS-694; ALA-1415; PRO-1503 AND ALA-1744. |
| [9] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 871-2157 (ISOFORM 1), VARIANTS PRO-1503 AND VAL-1895. Tissue: Uterine endothelium. |
| [10] | "Analysis of a high-throughput yeast two-hybrid system and its use to predict the function of intracellular proteins encoded within the human MHC class III region." Lehner B., Semple J.I., Brown S.E., Counsell D., Campbell R.D., Sanderson C.M. Genomics 83:153-167(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [11] | "Antibodies generated by a novel DNA vaccination identify the MHC class III encoded BAT2 polypeptide." Schneiders A., Thiel S., Winkler J., Moeller P., Koch N. Vaccine 23:2540-2550(2005) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION, DEVELOPMENTAL STAGE. |
| [12] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-342; SER-350 AND SER-1089, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [13] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [14] | "Phosphoproteome of resting human platelets." Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A. J. Proteome Res. 7:526-534(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1219, MASS SPECTROMETRY. Tissue: Platelet. |
| [15] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-380; SER-383; SER-456; THR-610; SER-759; SER-761; SER-764; SER-1014; SER-1085; SER-1089; SER-1092; TYR-1094; SER-1147 AND SER-1306, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [16] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-380; SER-456; THR-610; SER-761 AND SER-1089, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [17] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed] [Europe PMC] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-27 AND LYS-1196, MASS SPECTROMETRY. |
| [18] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-380; SER-808; SER-1219; THR-1353 AND SER-2113, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [19] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [20] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-342; SER-350; SER-380; SER-1089; SER-1110 AND SER-1219, MASS SPECTROMETRY. |
| [21] | "The consensus coding sequences of human breast and colorectal cancers." Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V. Velculescu V.E.Science 314:268-274(2006) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS [LARGE SCALE ANALYSIS] ILE-1087 AND HIS-1152. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | M33509 mRNA. Translation: AAA35585.1. Frameshift. M33518, M33512 Genomic DNA. Translation: AAA35586.1. Frameshift. AB210034 mRNA. Translation: BAE06116.1. Different initiation. AF129756 Genomic DNA. Translation: AAD18086.1. CR354443 Genomic DNA. Translation: CAQ06970.1. BA000025 Genomic DNA. Translation: BAB63391.1. AL662847 Genomic DNA. Translation: CAI17698.2. AL662801 Genomic DNA. Translation: CAI18313.1. AL805934 Genomic DNA. Translation: CAI18500.1. BX511262 Genomic DNA. Translation: CAI95572.1. CR753892 Genomic DNA. Translation: CAQ06959.1. CR759761 Genomic DNA. Translation: CAQ10847.1. CH471081 Genomic DNA. Translation: EAX03452.1. BC030127 mRNA. Translation: AAH30127.1. BC032134 mRNA. Translation: AAH32134.1. BC042295 mRNA. Translation: AAH42295.1. BC060668 mRNA. Translation: AAH60668.1. Z15025 Genomic DNA. Translation: CAA78744.1. Frameshift. CR749245 mRNA. Translation: CAH18101.1. |
| IPI | IPI00010700. IPI00084746. IPI00642817. IPI00885161. |
| PIR | B35098. S37671. |
| RefSeq | NP_004629.3. NM_004638.3. NP_542417.2. NM_080686.2. |
| UniGene | Hs.123239. Hs.436093. |
3D structure databases | |
| ProteinModelPortal | P48634. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | P48634. 32 interactions. |
| MINT | MINT-1032109. |
| STRING | 9606.ENSP00000404619. |
Polymorphism databases | |
| DMDM | 296439424. |
Proteomic databases | |
| PaxDb | P48634. |
| PRIDE | P48634. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000376007; ENSP00000365175; ENSG00000204469. ENST00000376033; ENSP00000365201; ENSG00000204469. ENST00000383455; ENSP00000372947; ENSG00000206427. ENST00000383464; ENSP00000372956; ENSG00000206427. ENST00000414956; ENSP00000404619; ENSG00000226618. ENST00000416335; ENSP00000415182; ENSG00000231370. ENST00000422962; ENSP00000415363; ENSG00000231825. ENST00000428775; ENSP00000387910; ENSG00000225164. ENST00000430737; ENSP00000413977; ENSG00000231825. ENST00000432252; ENSP00000408226; ENSG00000225748. ENST00000435971; ENSP00000409444; ENSG00000225164. ENST00000439762; ENSP00000400540; ENSG00000231370. ENST00000454306; ENSP00000387477; ENSG00000225748. ENST00000458561; ENSP00000396812; ENSG00000226618. |
| GeneID | 7916. |
| KEGG | hsa:7916. |
| UCSC | uc003nvb.4. human. |
Organism-specific databases | |
| CTD | 7916. |
| GeneCards | GC06P031594. |
| HGNC | HGNC:13918. PRRC2A. |
| HPA | CAB026383. |
| MIM | 142580. gene. |
| neXtProt | NX_P48634. |
| PharmGKB | PA25263. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG271062. |
| HOVERGEN | HBG004820. |
| InParanoid | P48634. |
| OMA | YSYERVG. |
| OrthoDB | EOG4G7BXH. |
| PhylomeDB | P48634. |
Gene expression databases | |
| ArrayExpress | P48634. |
| Bgee | P48634. |
| Genevestigator | P48634. |
Family and domain databases | |
| InterPro | IPR009738. BAT2_N. [Graphical view] |
| Pfam | PF07001. BAT2_N. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChiTaRS | PRRC2A. human. |
| GenomeRNAi | 7916. |
| NextBio | 30387. |
| SOURCE | Search... |
Entry information
| Entry name | PRC2A_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P48634 Secondary accession number(s): B0UX77 Q96QC6 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 6 Human chromosome 6: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |

Clusters with
